feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

School holiday on December 10

trending

Hindustan Zinc shares rally 4%

trending

UIDAI bans Aadhaar photocopies

trending

UP Police SI ASI Result

trending

IOCL flyover upkeep agreement

trending

Sensex falls on US Fed

trending

India vs South Africa T20I

trending

Uber launches Uber Direct

trending

Vivo X300 series launched India

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Roche's New Test Tackles Vaginitis Challenges

Roche's New Test Tackles Vaginitis Challenges

10 Dec

•

Summary

  • New assay diagnoses bacterial vaginosis and yeast infections using one swab.
  • Addresses limitations of current unreliable diagnostic methods.
  • Expands sexual health testing alongside STIs with a single sample.
Roche's New Test Tackles Vaginitis Challenges

Roche has secured CE Mark approval for its innovative cobas bacterial vaginosis/candida vaginitis (BV/CV) assay, designed to accurately diagnose common causes of vaginitis. This new diagnostic tool utilizes vaginal samples collected via a single swab, significantly streamlining the testing process for symptomatic patients. Unlike traditional methods such as microscopy and pH testing, which often yield ambiguous results, this polymerase chain reaction (PCR) assay offers precise identification of bacterial and yeast infections.

The development aims to mitigate the risks associated with delayed or incorrect treatments, which can lead to prolonged discomfort and potentially serious health complications. By providing rapid and accurate diagnostic information, healthcare professionals can quickly prescribe the most effective therapies, thereby improving patient outcomes and reducing the burden on healthcare systems. The assay's ability to detect infections swiftly ensures faster relief for patients experiencing symptoms like burning, itching, and discharge.

Furthermore, the cobas BV/CV assay enhances Roche's sexual health portfolio by enabling concurrent testing for BV, CV, and various sexually transmitted infections, including gonorrhea, chlamydia, and trichomonas, from the same sample. This integrated approach is compatible with Roche's cobas 5800, 6800, and 8800 systems, offering efficient workflows for clinics and laboratories. The assay is now available in countries recognizing the CE Mark, with potential to expand diagnostic capabilities globally.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Roche's cobas BV/CV assay is a new diagnostic tool that uses a single vaginal swab to accurately identify bacterial vaginosis and candida vaginitis.
It provides precise results from a single PCR test, overcoming the limitations and unreliability of older diagnostic methods like microscopy and pH testing.
Yes, the assay allows for BV and CV testing alongside sexually transmitted infections like gonorrhea and chlamydia using the same sample.

Read more news on

Healthside-arrow

You may also like

Is Your Toothbrush a Bacteria Breeding Ground? Expert Advice

1 day ago • 7 reads

article image

Flu & RSV Surge: Last Chance for Christmas Vax

5 Dec • 36 reads

article image

Gene Shutoff Kills Deadly TB Bacteria

4 Dec • 39 reads

article image

Herpes Virus Causes Rare Brain Swelling and Seizures

3 Dec • 30 reads

article image

Common Cold May Block COVID-19, Study Finds

29 Nov • 72 reads

article image